LDH/ADA ratio in pleural fluid for the diagnosis of infectious pleurisy

David Núñez-Jurado1, Isabel Rodríguez-Martín1, Juan Miguel Guerrero1

  • 1Department of Clinical Biochemistry, Virgen del Rocío University Hospital, Manuel Siurot Avenue, 41013, Seville, Spain.

PubMed

Insights

Diagnosing pleural effusion (PE) can be complex. This study found the lactate dehydrogenase to adenosine deaminase (LDH/ADA) ratio effectively distinguishes parapneumonic PE from other types, aiding diagnosis.

Area of Science:

  • Pulmonology
  • Medical Diagnostics
  • Biomarker Research

Background:

  • Pleural effusion (PE) is a common condition requiring diagnosis via thoracentesis.
  • Elevated pleural fluid adenosine deaminase (ADA) levels can suggest tuberculosis but lack specificity.
  • Accurate differentiation of PE types is crucial for appropriate patient management.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of pleural fluid biomarkers for PE.
  • To propose a novel diagnostic strategy for PE, particularly in patients with high ADA levels.
  • To differentiate between parapneumonic (PPE), tuberculous (TPE), malignant (MPE), and miscellaneous PE.

Main Methods:

  • Retrospective analysis of 259 patients with PE and elevated pleural fluid ADA (>33 U/L).
  • Analysis of demographic data, clinical information, and pleural fluid biomarkers including ADA and lactate dehydrogenase (LDH).
  • Development of a diagnostic decision tree based on key biomarkers and their ratios.

Main Results:

  • The LDH/ADA ratio demonstrated high sensitivity (98.06%) and specificity (98.08%) in distinguishing PPE from non-PPE.
  • A decision tree incorporating LDH/ADA ratio, ADA levels, and mononuclear cell percentage achieved 89.96% overall accuracy.
  • The developed decision tree effectively differentiated between the four studied types of PE.

Conclusions:

  • The pleural fluid LDH/ADA ratio is a valuable tool for differentiating PPE from other PE types.
  • A novel decision tree utilizing LDH/ADA ratio, ADA, and mononuclear cell percentage offers high accuracy for PE diagnosis.
  • This diagnostic strategy can improve the clinical management of patients with pleural effusion.

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
200
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
2.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
253
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
9